p53 activation can downregulate Xc− by inhibiting SLC7A11, these actions further reduces the expression of GSH and GPX4, leading to DN loss and motor deficits in the PD mouse model.(Li S. S. et al., 2021). Here, TP53 is linked to Parkinson disease.